Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01776021 · ClinicalTrials.gov registry record · NA

Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections

A NA study of Infection and Urinary Tract Infections, sponsored by Ocean Spray Cranberries.

Completed
Registry status
NA
Development phase
330
Enrollment target
17
Study locations

NCT01776021: Completed NA study of Infection and Urinary Tract Infections, sponsored by Ocean Spray Cranberries.

NCT01776021 is a NA study of Infection and Urinary Tract Infections that has completed, run by Ocean Spray Cranberries. The registered enrollment target is 330 participants, below the 718-participant average among 41 other Infection trials with a reported enrollment target (54% lower). The trial reports 17 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01776021, a NA study of Infection and Urinary Tract Infections, has completed, sponsored by Ocean Spray Cranberries.

COMPLETED
Registry status
NA
Development phase
330 participants
Enrollment target
17
Study locations

Study Summary

The purpose of this study is to compare the effects of a cranberry juice beverage on rates of Urinary tract infection (UTI) recurrence in women with a history of UTI.

Interventions

  • OTHER cranberry juice
  • OTHER placebo beverage

Study Locations (17)

Florida

  • - Edgewater
  • - Miami
  • - Summerfield

Arizona

  • - Chandler
  • - Scottsdale

California

  • - San Diego
  • - Santa Rosa

Illinois

  • Ocean Spray Cranberries Research Sites - Addison
  • - Evanston

Ohio

  • - Cincinnati
  • - Columbus

Utah

  • - Pleasant Grove
  • - Salt Lake City

Colorado

  • - Denver

Minnesota

  • - Edina

Trial Details

FieldValue
Enrollment Target 330 participants
Start Date 2013-01
Est. Completion 2015-04
Phase NA
Ocean Spray Cranberries

6 total trials

What the finished NCT01776021 record still lists

NCT01776021 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 718-participant average among 41 other Infection trials with a reported enrollment target (54% lower).

The record links to 3 conditions, with Infection appearing as the primary indexed condition, and to 2 interventions - of which cranberry juice is the first listed.

NCT01776021 lists 17 locations in 10 states (Florida, Arizona, California).

Frequently Asked Questions

What is clinical trial NCT01776021 about?

NCT01776021 is a clinical study titled "Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections". The purpose of this study is to compare the effects of a cranberry juice beverage on rates of Urinary tract infection (UTI) recurrence in women with a history of UTI.

What is the current status of trial NCT01776021?

This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2013-01. Estimated completion is 2015-04.

What conditions does trial NCT01776021 study?

This clinical trial studies the following conditions: Infection, Urinary Tract Infections, Urologic Diseases.

What interventions are being tested in trial NCT01776021?

The interventions under investigation include: cranberry juice (OTHER), placebo beverage (OTHER).

Who is sponsoring clinical trial NCT01776021?

This trial is sponsored by Ocean Spray Cranberries, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01776021 being conducted?

This trial has 17 study locations across Arizona, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01776021's enrollment target sits among peer trials

330 17th of 41 higher than 25 of 41 other Infection trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00359684 · 330 participants

    Use of Cysteamine in the Treatment of Cystinosis

  • NCT03817502 · 330 participants · Phase 3

    Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

  • NCT03922724 · 330 participants · Phase 2

    Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

  • NCT03932773 · 330 participants · NA

    Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01776021, the US trial registry maintained by the National Library of Medicine. NCT01776021 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.